Literature DB >> 10092882

Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.

M Hopf1, W Göhring, E Kohfeldt, Y Yamada, R Timpl.   

Abstract

Domain IV of mouse perlecan, which consists of 14 immunoglobulin superfamily (IG) modules, was prepared from recombinant human cell culture medium in the form of two fragments, IV-1 (IG2-9, 100 kDa) and IV-2 (IG10-15, 66 kDa). Both fragments bound to a heparin column, being eluted at ionic strengths either below (IV-2) or above (IV-1) physiological level, and could thus be readily purified. Electron microscopy demonstrated an elongated shape (20-25 nm), and folding into a native structure was indicated by immunological assay and CD spectroscopy. Solid-phase and surface plasmon resonance assays demonstrated strong binding of fragment IV-1 to fibronectin, nidogen-1, nidogen-2 and the laminin-1-nidogen-1 complex, with Kd values in the range 4-17 nM. The latter binding apparently occurs through nidogen-1, as shown by the formation of ternary complexes. Only moderate binding was observed for fibulin-2 and collagen IV and none for fibulin-1 and BM-40. Fragment IV-2 showed a more restricted pattern of binding, with only weaker binding to fibronectin and fibulin-2. None of these activities could be demonstrated for recombinant fragments corresponding to the N-terminal perlecan domains I to III. This indicates a special role for domain IV in the integration of perlecan into basement membranes and other extracellular structures via protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092882     DOI: 10.1046/j.1432-1327.1999.00127.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  52 in total

1.  Laminin deposition in the extracellular matrix: a complex picture emerges.

Authors:  Kevin J Hamill; Kristina Kligys; Susan B Hopkinson; Jonathan C R Jones
Journal:  J Cell Sci       Date:  2009-12-15       Impact factor: 5.285

Review 2.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 3.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

4.  Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Authors:  Muneaki Ishijima; Nobuharu Suzuki; Kentaro Hozumi; Tomoya Matsunobu; Keisuke Kosaki; Haruka Kaneko; John R Hassell; Eri Arikawa-Hirasawa; Yoshihiko Yamada
Journal:  Matrix Biol       Date:  2012-03-07       Impact factor: 11.583

Review 5.  Laminin isoforms in endothelial and perivascular basement membranes.

Authors:  Lema F Yousif; Jacopo Di Russo; Lydia Sorokin
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

Review 6.  The myotomal basement membrane: insight into laminin-111 function and its control by Sonic hedgehog signaling.

Authors:  Anne-Gaëlle Borycki
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

7.  A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.

Authors:  Mary C Farach-Carson; Anissa J Brown; Megan Lynam; Jeffrey B Safran; Daniel D Carson
Journal:  Matrix Biol       Date:  2007-10-10       Impact factor: 11.583

Review 8.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  DSS-induced damage to basement membranes is repaired by matrix replacement and crosslinking.

Authors:  Angela M Howard; Kimberly S LaFever; Aidan M Fenix; Cherie' R Scurrah; Ken S Lau; Dylan T Burnette; Gautam Bhave; Nicholas Ferrell; Andrea Page-McCaw
Journal:  J Cell Sci       Date:  2019-04-08       Impact factor: 5.285

Review 10.  Developmental and pathogenic mechanisms of basement membrane assembly.

Authors:  Peter D Yurchenco; Bruce L Patton
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.